期刊文献+

半乳糖基壳聚糖5氟尿嘧啶纳米粒的制备及其抑制小鼠结肠癌的实验研究 被引量:3

Preparation of 5-Fluorouracil Nanoparticles of Galactosylated Chitosan and Its Inhibition of the Colon Cancer in Mice
暂未订购
导出
摘要 目的:半乳糖基壳聚糖纳米材料与5-氟尿嘧啶(5-FU)合成5-FU纳米粒,并观察其在体内抑制小鼠结肠癌的疗效。方法:将体外培养的C26细胞接种小鼠肝左叶,成瘤后,分别用0.9%氯化钠液、空纳米粒、5-FU和5-FU纳米粒行尾静脉注射,观察5-FU纳米粒的抗肿瘤效果。用酶联免疫吸附试验法检测血清γ干扰素(IFN-γ)和白细胞介素-2(IL-2)含量,用四甲基偶氮唑盐(MTT)比色法测定小鼠脾自然杀伤细胞(NK细胞)和细胞毒性T细胞(CTL细胞)活性。结果:与0.9%氯化钠液组及纳米粒组相比,5-FU组和5-FU纳米粒组的瘤质量显著降低(P<(0.01),尤其5-FU纳米粒组降低更显著(P<0.01)。与其他各组比较,5-FU组小鼠,外周血IFN-γ和IL-2含量均显著降低(P<0.01),5-FU纳米粒组与0.9%氯化钠液组比较差异无统计学意义(P>0.05)。5-FU组的脾NK细胞和CTL细胞杀伤活性较其他各组显著降低(P<0.01),5-FU纳米粒组与0.9%氯化钠液组比较未见降低(P>0.05),纳米粒组NK和CTL杀伤活性0.9%氯化钠液组增高(P<0.05)。结论:5-FU纳米粒治疗结肠癌模型,具有明显抗肿瘤效应,纳米粒材料具有提高机体免疫功能,减低5-FU对机体免疫的抑制作用。 Objective:The 5-fluorouracil(5-Fu) nanoparticles of galactosylated chitosan was synthesized and the efficacy were observed in colon cancer model in vivo with 5-fluorouracil nanoparticles of galactosylated chitosan.Methods:C26 cells were cultured left lobe of the liver in mice,after tumor formation,models were treated with normal saline in NS group,empty nanoparticles in NP group,5-Fu nanoparticles in 5-Fu NP group and 5-Fu in 5-Fu group,respectively,via tail vein injection.Tumor weight were measured in the end of this experiment.The serum interferon-gamma(IFN-y) and interleukin-2(IL-2) were detected by enzyme-linked immunospot-based assays(ELISA),and natural killer(NK) cells and cytotoxic T lymphocytes(CTL) activity of mouse spleen were measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium(MTT) colorimetric assay. Results:Compared with NS group and NP group,the tumor weight in 5-Fu group and group was significantly lighter(P 0.01),the tumor weight decreased more obvious in 5-Fu NP group(P〈0.01).The levels of IFN-y and IL-2 of liver metastases of colon cancer model in mice decreased obviously in 5-Fu group than those in other groups(P〈0.01),however,the decrease of IFN-γand IL-2 in 5-Fu NP group was not obvious(P 〉0.05),compared with the saline group,while the levels in NP group was significantly higher than those in NS group(P〈0.01).The killing activity of NK and CTL in 5-Fu group was significantly lower than that in other groups(P〈0.01),however,the killing activity of NK and CTL in NP group increased compared with NS group(P〈0.05),and 5-Fu NP group was no lower compared with NS group(P〉 0.05).Conclusions: The 5-Fu nanoparticles have significant anti-tumor effect in colon cancer model,nanoparticle materials can stimulate immune function of mice and reduced the side effects of 5-Fu in immune suppression.
出处 《中国临床医学》 2011年第6期738-741,共4页 Chinese Journal of Clinical Medicine
基金 上海市自然基金项目(编号:09ZR1424700) 上海市闵行区自然基金项目(编号:2009MHZ085)
关键词 5氟尿嘧啶 壳聚糖 半乳糖 结肠癌肝转移 5-Fluorouracil Chitosan Galactose Colon cancer
  • 相关文献

参考文献9

  • 1Hyams DM. Clinical advances in treatment options and diag- nostics : new tools in the management of breast cancer and co- lon cancer[J]. Manag Care, 2010,19 ( 10 Suppl 4) : 3 11.
  • 2Kim CW, Shin US, Yu CS, et al. Clinicopathologic charac- teristics, surgical treatment and outcomes {or splenic flexure colon cancer[J]. 2010,42(2) :69 76.
  • 3Kim EM, Jeong HJ, Kim SL, et aI. Asialoglycoprotein-re ceptor targeted hepatoeyte imaging using 99mTc galaetosylat ed chitosan[J]. Nucl Med Biol,2006,33(4):529 534.
  • 4YangW, MouT, GuoW, et al. Fluorine-18 labeled galacto sylated chitosan for asialoglycoprotein-receptor-mediated hep atocyteimaging[J]. Bioorg Med Chem Lett,2010,20(16): 4840-4844.
  • 5Bertolla C, Rolin S, Evrard B, et al. Synthesis and pharma- cological evaluation of a new targeted drug carrier system: beta cyclodextrin coupled to oxytocin[J]. Bioorg Med Chem Lett, 2008,18(6) :1855 1858.
  • 6Sorensen A L, Rumjantseva V, Nayeb Hashemi S, et al. Role of sialic acid for platelet life span: exposure of beta-ga lactose results in the rapid clearance of platelets from the cir eulation by asiaoglycoprotein rophages and hepatocytes[J] 1654. receptor-expressing liver mac- Blood, 2009, 114(8): 1645.
  • 7Li Y, Huang G, Diakur J, et al. Targeted delivery of macro- molecular drugs: asialoglycoprotein receptor (ASGPR) ex- pression by selected hepatoma cell lines used in antiviral drug development[J]. Curr Drug Deliv, 2008,5 (4) : 299-302.
  • 8Kuppner MC, Bleiuss E, Noessner E, et al. Differential effects of ifosfamide on dendritic cell-mediated stimulation of T cell interleukin 2 production, natural killer cell cytotoxieity and interferon-gamma production E J2. Clin Exp Immunol, 2008,153(3) :429-438,.
  • 9Moriai S, Takahara M, Ogino T, et al. Production of inter- feron-{gamma} inducible protein-10 and its role as an auto- crine invasion factor in nasal natural killer/T-cell lymphoma cells[J]. Clin Cancer Res, 2009,15(22):6771-6779.

同被引文献42

  • 1钟玲,李思齐,杨蔚,曾蓉,毛琴,陈嘉勇.转铁蛋白受体介导载紫杉醇纳米粒对结肠癌细胞的靶向性研究[J].中国生化药物杂志,2014,34(5):23-25. 被引量:5
  • 2李镠洋,卿三华,盛新华,巴明臣.Profrin II纳米微粒光动力疗法抑制人结肠癌裸鼠种植瘤的实验研究[J].临床和实验医学杂志,2006,5(5):514-516. 被引量:3
  • 3卿三华,李镠洋,盛新华,巴明臣.纳米微粒光敏剂光动力治疗结肠癌的实验研究[J].中华胃肠外科杂志,2006,9(6):530-533. 被引量:1
  • 4周平红.磁性阿霉素纳米脂质体靶向治疗裸鼠大肠癌的实验研究[D].上海:复旦大学,2003.
  • 5Maksimenko A , Alami M, Zouhiri F, et aJ. Therapeutic modalitiesof squalenoyl nanocomposites in colon cancer: an ongoing search forimproved efficacy [ J ]. ACS Nano, 2014 , 8(3): 2018-2032.DOI: 10. 1021/nn500517a.
  • 6Huang H, Pierstorff E,Osawa E , et al. Active nanodiamond hy-drogels for chemotherapeutic delivery [ J ]. Nano Lett, 2007 , 7(11): 3305-3314. DOI: 10.1021/nl071521o.
  • 7Hu Q, Liang B, Sun Y, et al. Preparalion of bufalin-loaded plu-ronic polyetherimide nanoparticles,cellular uptake, distribution,and effect on colorectal cancer[ J]. Int J Nanomed, 2014 , 9(1):4035-4041. DOI: 10.2147/IJN. S64708.
  • 8Yin PH, Wang Y, Qiu YY, et al. Bufalin-loaded mPEG-PLGA-PLL- cRGD nanoparticles : Preparation,cellular uptake,tissue distri-bution ,and anticancer activity [ J ]. lnl J Nanomed, 2012 , 7:3961-3969.
  • 9Pramod PS, Shah R, Chaphekar S, et al. Polysaccharide nano- ve-sicular multidrug carriers for synergistic killing of cancer cells [ J ].Nanosoale, 2014, 6 ( 20 ): 11841-11855. DOI: 10. 1039/C4NR03514C.
  • 10Garg A, Tisdale A W, Haidari E, el al. Targeting colon cancercells using PEGylated liposomes modified with a fibronectin-mimel-ic peplide[J]. Int J Pharm, 2009,366(1/2) : 201-210. DOI:10. 1103/PhysRevC.52. 1047.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部